ArticleBMC cancer2024

Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study.

Mari Uomoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.